Vera Therapeutics's market cap is currently $1.87B. The company's EPS TTM is $-2.599; its P/E ratio is ―; Vera Therapeutics is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $-0.81. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 1.86M	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 1.86M	$ 846.00K	$ -176.00K	$ -251.00K	$ -509.00K
Operating Income	$ -102.01M	$ -90.90M	$ -34.40M	$ -52.24M	$ -11.96M
EBITDA	$ -102.01M	$ -90.90M	$ -34.23M	$ -52.99M	$ -11.19M
Net Income	$ -95.99M	$ -89.06M	$ -32.61M	$ -53.41M	$ -11.85M
Balance Sheet
Cash & Short-Term Investments	$ 160.72M	$ 114.65M	$ 79.67M	$ 53.65M	$ 3.19M
Total Assets	$ 175.55M	$ 131.44M	$ 83.75M	$ 54.55M	$ 5.38M
Total Debt	$ 53.71M	$ 31.29M	$ 4.92M	$ 2.00K	$ 132.00K
Net Debt	$ 8.03M	$ -83.37M	$ -74.75M	$ -53.65M	$ -3.06M
Total Liabilities	$ 73.86M	$ 54.53M	$ 14.16M	$ 143.90M	$ 41.93M
Stockholders' Equity	$ 101.69M	$ 76.91M	$ 69.59M	$ -89.35M	$ -36.55M
Cash Flow
Free Cash Flow	$ -92.24M	$ -67.66M	$ -23.71M	$ -34.91M	$ -10.41M
Operating Cash Flow	$ -92.18M	$ -67.60M	$ -23.71M	$ -34.81M	$ -10.29M
Investing Cash Flow	$ -39.43M	$ -70.55M	$ -4.20M	$ -42.00K	$ -125.00K
Financing Cash Flow	$ 133.54M	$ 101.93M	$ 53.88M	$ 85.29M	$ -137.00K

Currency in USD

Vera Therapeutics Earnings and Revenue History

Income Statement >

Vera Therapeutics Debt to Assets

Balance Sheet >

Vera Therapeutics Cash Flow

Cash Flow >

Vera Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing